Cosmetic Ingredient Review Report Status

Chart: Data compiled by the Rose Sheet from information in CIR reports following the Expert Panel's Dec. 4-5 meeting.

(a) when formulated to be non-irritating

(b) Safe as used in hair colorants and hair lighteners designed for brief discontinuous use followed by thorough rinsing from...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Ingredients & Safety

EU VMS Max Levels Should Aim At ‘Optimal Health’ Not Just Deficiency

 
• By 

“The European Commission’s work on harmonizing maximum levels of vitamins and minerals should fully reflect the positive role that food supplements can play in safely and effectively addressing micronutrient gaps,” insists Food Supplements Europe chair Peter Loosen.

European Regulators And Industry Stand By Paracetamol Safety After US Warning

 
• By 

EMA and MHRA among European regulators reiterating the safety of paracetamol use by pregnant women following news FDA will require OTCs to carry label warning.

EFSA Suggests 2mg Daily CBD Limit, Cannot Establish Safe Intake For Under 25s

 
• By 

EFSA is consulting on a provisional CBD safe dose of 2mg for a 70kg adult and has stated that the safety of CBD cannot be established for individuals under 25 years of age, pregnant or lactating women, and those on existing medications.

Just One More Step Before The First Legal UK CBD Food Supplements

 
• By 

UK CBD food supplement applications from Chanelle McCoy, Cannaray Brands and the European Industrial Hemp Association pass FSA's safety assessment stage and are now out for consultation. After that, only government approval stands in their way, with five years exclusivity the icing on the cake.

More from HBW Insight

US FDA Program Encouraging Domestic Manufacturing May Be ‘Very Selective’

 

Pharmaceutical manufacturers encouraged FDA to consider including expansions and modifications of existing US facilities in PreCheck program.

Futura Looks To Refine Eroxon Messaging To Help Sales

 
• By 

A strategic review of Eroxon has identified an “over-expectation" of what the product will deliver requiring a more refined marketing approach.

EU VMS Max Levels Should Aim At ‘Optimal Health’ Not Just Deficiency

 
• By 

“The European Commission’s work on harmonizing maximum levels of vitamins and minerals should fully reflect the positive role that food supplements can play in safely and effectively addressing micronutrient gaps,” insists Food Supplements Europe chair Peter Loosen.